Name: GANX Balance Sheet - Gain Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

GANX - Gain Therapeutics, Inc.

USD | NASDAQ | Healthcare

GANX Balance Sheet - Gain Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19
Cash And Short Term Investments
Cash And Equivalents	16.5	20.8	8.8	6.7	9.1	10.4	12.0	16.9	10.6	11.8	4.3	6.3	6.0	7.3	10.9

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Cash And Short Term Investments
Cash And Equivalents	20.8	10.4	11.8	7.3	36.9	7.5	-
Restricted Cash	-	-	-	-	-	0.0	-
Short Term Investments	-	-	5.0	12.8	-	-	-
Cash And Short Term Investments	20.8	10.4	16.8	20.1	36.9	7.5	-
Receivables
Accounts Receivable	-	-	-	-	-	0.0	-
Current Assets
Inventory	-	-	-	-	-	-	-
Prepaid Expenses	1.2	0.9	0.7	0.8	0.7	0.2	-
Non-Current Assets
Property, Plant & Equipment Gross	0.3	0.2	0.2	0.2	0.1	0.0	-
Accumulated Depreciation	0.2	0.1	0.1	0.1	0.0	0.0
Current Liabilities
Accounts Payable	0.8	0.9	1.3	1.6	0.6	1.0	-
Short Term Debt	0.1	0.1	0.1	0.1	0.1	0.0	-
Non-Current Liabilities
Long Term Debt	0.3	0.3	0.4	0.5	0.6	0.7	-
Operating Lease Liabilities Non-Current	0.2	0.1	0.2	0.4	0.7	0.4
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	119.1	88.8	73.1	57.4	55.8	13.4
Supplementary Data
Total Debt	0.4	0.4	0.6	0.6	0.7	0.7	-
Net debt	(20.4)	(9.9)	(16.2)	(19.5)	(36.2)	(6.8)	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	1.5	1.2	1.4	2.3	1.8	0.9	1.3	1.3	1.0	0.7	0.9	1.0	1.4	0.8	1.6	1.5	1.9	0.7
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	18.2	22.2	10.5	9.3	11.2	11.6	13.7	18.5	13.9	17.8	13.2	17.3	19.3	21.1	24.3	25.8

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-
Additional Paid In Capital	120.0	119.1	102.2	94.6	91.6	88.8	86.1	84.7	73.4	73.1	63.3	62.3	58.7	57.4	56.8	56.4	56.1
Retained Earnings	(101.4)	(81.2)	(81.2)	(81.2)	(81.2)	(60.8)	(60.8)	(60.8)	(60.8)	(38.5)	-	-	(38.5)	(20.9)	(20.9)	(20.9)	(20.9)
Accumulated Other Comprehensive Income	1.0	0.8	0.6	0.6	(0.1)	(0.2)	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.0	(0.3)	(0.1)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	14.0	18.6	5.9	3.7	5.8	7.3	8.9	11.8	8.6	12.6	7.3	11.1	15.1	18.9	22.7	27.0	31.8
Total Equity	14.0	18.6	5.9	3.7	5.8	7.3	8.9	11.8	8.6	12.6	7.3	11.1	15.1	18.9	22.7	27.0	31.8	34.8